Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA3 | P34903 | 11/20 | 0.56 |
| ▸ | GABRA5 | P31644 | 8/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 7/20 | 0.56 |
| ▸ | GABRA2 | P47869 | 7/20 | 0.56 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.56 |
| ▸ | GABRG2 | P18507 | 8/20 | 0.49 |
| ▸ | GABRB3 | P28472 | 8/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.35 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7308306 | 0.90 | GABRA3 (0.62) | GABRA3GABRA5GABRA1GABRA2GABRB2 | |
| SCHEMBL3417353 | 0.87 | GABRA3 (0.67) | GABRA3GABRA5GABRA1GABRA2GABRB2 | |
| SCHEMBL3417352 | 0.85 | GABRA3 (0.53) | GABRA3GABRA5GABRA1GABRA2GABRB2 | |
| SCHEMBL7312677 | 0.82 | GABRA5 (0.57) | GABRA3GABRA5GABRA1GABRA2GABRB2 | |
| SCHEMBL11629048 | 0.79 | GABRG2 (0.74) | GABRA3GABRA5GABRA1GABRA2GABRB2 | |
| SCHEMBL11705443 | 0.78 | GABRA1 (0.76) | GABRA3GABRA5GABRA1GABRA2GABRB2 | |
| SCHEMBL3415178 | 0.76 | GABRG2 (0.77) | GABRA3GABRA5GABRA1GABRA2GABRB2 | |
| SCHEMBL7311148 | 0.74 | GABRA3 (0.70) | GABRA3GABRA5GABRA1GABRA2GABRB2 | |
| SCHEMBL11709742 | 0.74 | GABRA3 (0.66) | GABRA3GABRA5GABRA1GABRA2GABRB2 | |
| SCHEMBL11035825 | 0.73 | GABRA5 (0.41) | GABRA3GABRA5GABRA1GABRA2GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100261711-A1 | SELECTIVE ANTICONVULSANT AGENTS AND THEIR USES | WISYS TECHNOLOGY FOUNDATION (US) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261711-A1 | SELECTIVE ANTICONVULSANT AGENTS AND THEIR USES | GABRA5, GABRA6, GABRA2 | GABRA3 5/4885GABRA5 1/4885GABRA1 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.